Julius Clinical
Academic and clinical research organization.
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
---|---|---|---|---|---|
Revenues | 42.4m | 50.3m | 32.3m | - | - |
% growth | - | 18 % | (36 %) | - | - |
EBITDA | 5.4m | 3.2m | 4.0m | (4.9m) | (3.6m) |
% EBITDA margin | 13 % | 6 % | 12 % | - | - |
Profit | 7.7m | 2.2m | 2.8m | (3.6m) | (3.5m) |
% profit margin | 18 % | 4 % | 9 % | - | - |
R&D budget | - | 9.0m | 10.0m | 4.0m | 4.0m |
R&D % of revenue | - | 18 % | 31 % | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
* | N/A | Growth Equity VC | |
Total Funding | - |
Related Content
Recent News about Julius Clinical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.